Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Temporary faecal diversion in ileocolic resection for Crohn’s disease: is there an impact on long‐term surgical recurrence?

Bolckmans R. et al, (2020), Colorectal Disease, 22, 430 - 438

Loss of IL-10 signaling in macrophages limits bacterial killing driven by prostaglandin E2.

Mukhopadhyay S. et al, (2020), The Journal of experimental medicine, 217

Remission of Inflammatory Bowel Disease in Glucose-6-Phosphatase 3 Deficiency by Allogeneic Haematopoietic Stem Cell Transplantation

Bolton C. et al, (2020), Journal of Crohn's and Colitis, 14, 142 - 147

Does Smoking Cessation Reduce Surgical Recurrence After Primary Ileocolic Resection for Crohn's Disease?

Bolckmans R. et al, (2019), Dis Colon Rectum

Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study

Snowden JA. et al, (2019), BMC Gastroenterology, 19

Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data.

Card T. et al, (2019), Alimentary pharmacology & therapeutics

Management of Pouch-Vaginal Fistulae - experience from our institution.

Sivathondan PC. et al, (2019), Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Is Crohn's disease a rightly used eponym?

Van Hootegem P. and Travis S., (2019), Journal of Crohn's & colitis

IM-UNITI at Three Years: Stellar Stelara® or Stardust? The Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.

Travis S., (2019), Journal of Crohn's & colitis

Host-microbial crosstalk in the pathogenesis of inflammation and cancer in Primary Sclerosing Cholangitis (PSC)

Neyazi M. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 941 - 941

TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions

Leng T. et al, (2019), Cell Reports, 28, 3077 - 3091.e5

The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn's Disease: 4 Years of Global Post-Marketing Data.

Cohen RD. et al, (2019), J Crohns Colitis

Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy study.

Taylor SA. et al, (2019), Health Technol Assess, 23, 1 - 162

Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial.

Panaccione R. et al, (2019), Gut

Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis.

Walsh A. et al, (2019), Intest Res

Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life.

Bryant RV. et al, (2019), Inflamm Bowel Dis, 25, e62 - e63

Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.

Walsh A. et al, (2019), J Crohns Colitis, 13, 424 - 430

Can patients enter the 'Standard Set' ICHOM parameters by completing electronic questionnaires?

Walsh A. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S140 - S141

Could an escalation of therapy or intervention (ETI) calculator be used to triage appointments for patients with ulcerative colitis?

Walsh A. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S397 - S398

Endoscopic and deep remission at 1 year prevents disease progression in early Crohn's disease: long-term data from CALM

Yzet C. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S24 - S25

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?